Form D · Biotechnology
ENTREMED INC
Rockville, MD · CIK 0000895051
Offering snapshot reported Feb 15, 2012 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 2, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 15, 2012 | Initial | $10,000,000 | No comparison | 16 | SEC filing |
| Feb 22, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 21, 2006 | Paper | Not reported | No comparison | Not reported | |
| Jan 19, 2006 | Paper | Not reported | No comparison | Not reported | |
| Jan 13, 2005 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-173506
Source: Form D, filed Feb 15, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Bray | Executive |
| Dwight L. Bush | Director |
| Sara B. Capitelli | Executive |
| Wei Wu He | Director |
| Cynthia W. Hu | Executive |
| Jennie C. Hunter Cevera | Director |
| Tak W. Mak | Director |
| Mark C.M. Randall | Director |
| Carolyn F. Sidor | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9640 Medical Center Drive
Rockville, MD, 20850
Rockville, MD, 20850